Amerisourcebergen

Amerisourcebergen FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Amerisourcebergen (ABC) as of Nov 5, 2026 is 129.90 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 144.71 % — a change of -10.23% (lower).

FCF Conversion

129.90 %

YoY

-10.23%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Amerisourcebergen is 2022 129.90 % . FCF Conversion Rate (FCF/EBITDA) of Amerisourcebergen was 2021 144.71 % . It decreases by -10.23% lower compared to the previous year.

The Amerisourcebergen FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2015
-2,734.73 USD
Jan 1, 2016
190.06 USD
Jan 1, 2017
246.72 USD
Jan 1, 2018
64.82 USD
Jan 1, 2019
237.77 USD
Jan 1, 2020
-54.05 USD
Jan 1, 2021
144.71 USD
Jan 1, 2022
129.90 USD
The Amerisourcebergen FCF Conversion history
YEARFCF ConversionYoY
129.90 %-10.23%
144.71 %-367.74%
-54.05 %-122.73%
237.77 %+266.82%
64.82 %-73.73%
246.72 %+29.81%
190.06 %-106.95%
-2,734.73 %-730.78%
433.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amerisourcebergen Stock analysis

What does Amerisourcebergen do? AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amerisourcebergen stock

FCF Conversion Rate (FCF/EBITDA) of Amerisourcebergen is 129.90 % in 2022.

FCF Conversion Rate (FCF/EBITDA) of Amerisourcebergen changed from 144.71 % to 129.90 %, representing a -10.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Amerisourcebergen since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Amerisourcebergen with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Amerisourcebergen

All Key Metrics — Amerisourcebergen